VF
SHPH icon

Virtu Financial’s Shuttle Pharmaceuticals SHPH Stock Holding History

Virtu Financial’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Buy
+1,238
New +$16.8K ﹤0.01% 1475
2024
Q3 		– Sell
-6
Closed -$5K – 1838
2024
Q2 		$5K Buy
6
+1
+20% +$849 ﹤0.01% 1185
2024
Q1 		$4K Sell
5
-5
-50% -$4.21K ﹤0.01% 1302
2023
Q4 		$9K Buy
+10
New +$10.2K ﹤0.01% 1421
2023
Q1 		– Sell
-8
Closed -$31K – 2044
2022
Q4 		$31K Sell
8
-1
-11% -$4.86K ﹤0.01% 1179
2022
Q3 		$78K Buy
+9
New +$367K 0.01% 1132

Other funds holding SHPH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's SHPH Position: Q1 2026 in Review

Virtu Financial opened a new position in Shuttle Pharmaceuticals (SHPH) in Q1 2026: 1,238 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #1475 among its holdings. This is a return to the name: Virtu Financial previously reported a position in SHPH as recently as Q2 2024.

Virtu Financial first reported a position in SHPH in Q3 2022 and has held it in 6 quarters since. The position peaked at $78K in Q3 2022. 8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

  • Virtu Financial held 1,238 shares of Shuttle Pharmaceuticals worth $8K as of Q1 2026.
  • Shuttle Pharmaceuticals was a new Virtu Financial position in Q1 2026.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1475 holding.
  • Virtu Financial first reported a position in Shuttle Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
  • Virtu Financial's Shuttle Pharmaceuticals position peaked at $78K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.